Publications

1/ Analysis of the cellular origin of T15 idiotype.
P.A CAZENAVE, H. MASMOUDI, T. MOTA-SANTOS, A. COUTINHO.
In : Idiotypic networks in Biology and Medicine.
Elsevier Science Publishers, Amsterdam, 1990, 65 – 68.

2/ Immunologie fondamentale et immunopathologie à l’usage des étudiants en Médecine, Biologie et Pharmacie .
Hatem MASMOUDI et Amel EL GAAIED BEN AMMAR.
Centre de Publications Universitaire de Tunis, Collection Sciences Médicales, Décembre 2000.
Ouvrage de 272 pages et 21 chapitres (nous avons rédigé 19 des 21 chapitres).

3/ Les prélèvements en Immunologie. H. MASMOUDI.
In : Les prélèvements en biologie clinique.
S. GARGOURI, A. BEN AMOR, N. BOUJAAFAR, A. HEDHILI, H. MASMOUDI, A. OUESLATI, A. SLIM, M. A. MEMMI.
Unité des laboratoires de biologie médicale, Ministère de la Santé Publique, Novembre 2001, p 44 – 47.

4/ Présentation générale du système immunitaire.
M. BEN AYED, S. HADDOUK, H. MASMOUDI.
In : Abrégé de physiologie à l’usage des acupuncteurs et des réflexothérapeutes.
Sous la direction d’Yves ROUXEVILLE. Springer. Paris, 2013.

5/ Immunité et réinfection par le nouveau coronavirus : entre mythe et réalité.
In : Covid-19 : La Tunisie abassourdie.
Ouvrage collectif sous la direction de Taoufik Habaieb, Leaders 2021

1/ LES FREQUENCES GENIQUES DES GROUPES SANGUINS ABO ET RHESUS DANS LA POPULATION TUNISIENNE.
H. MASMOUDI, A. ZAIEM.
La Tunisie Médicale, Vol. 64, N° 6 – 7, Juin – Juillet 1986, 586 – 585.

2/ AUTO-ANTICORPS ANTI-IDIOTYPIQUES DES ANTICORPS ANTI-DNA DANS LE LUPUS ERYTHEMATEUX DISSEMINE.
H. MASMOUDI, S. MAKNI, J.F BACH.
La Tunisie Médicale, Vol.67, N° 10, Octobre 1989, 617 – 620.

3/ NEW ALLOTYPES OF THE MURINE GAMMA 1 IMMUNOGLOBULINS.
H. MASMOUDI, F. BONHOMME, P.A CAZENAVE.
Molecular Immunology, 1989, 26, 551 – 555.

4/ DIVERGENCY IN THE SPECIFICITY OF THE INDUCTION AND MAINTENANCE OF NEONATAL SUPPRESSION (T. MOTA-SANTOS, H. MASMOUDI, D. VOEGTLE, A. FREITAS, A. COUTINHO, P.A CAZENAVE.
European Journal of Immunology. 1990, 20, 1717 – 1721.

5/ ALL T15 ID-POSITIVE ANTIBODIES (BUT NOT THE MAJORITY OF VHT15 ANTIBODIES) ARE PRODUCED BY PERITONEAL CD5+ B
LYMPHOCYTES.
H. MASMOUDI, T. MOTA-SANTOS, F. HUETZ, A. COUTINHO, P.A CAZENAVE.
International Immunology, 1990, Vol.2, N°6, 515 – 520.

6/ ASTHME PROFESSIONNEL AU BOIS : A PROPOS D’UN CAS.
D. REBAI, T. MAKKI, M. AYADI, F.M JAMOUSSI, H. MASMOUDI.
Maghreb Medical, Novembre 1993, N°273, 16 – 18.

7/ HEPATITE VIRALE C CHEZ LES HEMODIALYSES CHRONIQUES DANS LE SUD TUNISIEN : PREVALENCE ET FACTEURS DE RISQUE.
J. HACHICHA, A. HAMMAMI, H. MASMOUDI, M. BEN HMIDA, M. KHARRAT, F. KAMMOUN, A. JARRAYA.
Annales de Médecine Interne. 1995, 146, N°5, 295 – 298.

8/ BARE LYMPHOCYTE SYNDROME TYPE II. A PROPOS D’UN CAS.
H. MASMOUDI, M.R BARBOUCHE, A. MAHFOUDH, T. KAMMOUN, R. BARDI, M. BEJAOUI, R. LAKHOUA, M. HACHICHA, K. AYED, K. DELLAGI, A. TRIKI.
Revue maghrébine de pédiatrie. Volume VI, N°2, 89 –92, Mars – Avril 1996,

9/ MYELOPATHIES LUPIQUES ET ANTICORPS ANTI-PHOSPHOLIPIDES : 2 CAS.
I. FEKI, M. BEN HMIDA, H. MASMOUDI, C. TRIKI, Z. BAHLOUL, J. HACHICHA, R. JLIDI, C. MHIRI.
Revue de Neurologie. Paris. 1997, 153 : 2, 138 – 40.

10/ ERYTHROBLASTOPENIE CHRONIQUE ASSOCIEE A UNE GAMMAPATHIE MONOCLONALE ET A UN LUPUS : A PROPOS D’UN CAS.
H. MASMOUDI, M. ELLOUMI, M. FRIKHA, S. MSEDDI, M. BOUAZIZ, T. SOUISSI.
Semaine des Hôpitaux. Février 1997, N° 5 – 6, 159 – 162.

11/ LE CONTROLE DE QUALITE DANS L’IMMUNODOSAGE DES MARQUEURS TUMORAUX CIRCULANTS AFP, ACE ET CA15-3.
M. BEN AYED, Y. BEN HADJ HMIDA, M. KASSIS, J. DAMAK, H. MASMOUDI.
Biologie Clinique. Novembre 1998, N°9, 27 – 33.

12/ EPANCHEMENT PLEURAL PLASMOCYTAIRE REVELATEUR D’UN MYELOME MULTIPLE.
M. ELLOUMI, M. FRIKHA, H. MASMOUDI, S. MSEDDI, M. BEN AYED, M. BOUAZIZ, F. MAKNI, T. SOUISSI.
Revue des maladies respiratoires. 2000, 17, 495 – 497.

13/ PRESENCE ISOLEE DE L’ANTICORPS ANTI-HBC : PREVALENCE ET INTERPRETATION A L’AIDE DES RESULTATS DE RECHERCHE DE L’ADNVIRAL ET DU DOSAGE DES ANTICORPS ANTI-HBS APRES VACCINATION.
M. BEN AYED, H. TRIKI, D. COINTE, H. KARRAY, M.A MASMOUDI, K. DELLAGI, L. GRANGEOT, A. HAMMAMI, H. MASMOUDI.
Annales de Biologie Clinique. Janvier-Février 2001, vol. 59, n°1, 53 – 60.

14/ MENINGITE CARCINOMATEUSE REVELATRICE DE CANCER : ETUDE DE DEUX CAS.
S. SAMET, F. BELAHSEN, Ch. TRIKI, H. MASMOUDI, R. JLIDI, Ch. MHIRI.
La Tunisie Médicale. Avril 2001, vol. 79, n°04, 257 – 260.

15/ LE CONTROLE DE QUALITE DANS LE DOSAGE DES MARQUEURS TUMORAUX : METHODOLOGIE, RESULTATS ET PROBLEMES POSES.
M. BEN AYED, Y. BEN HADJ HMIDA, M. KASSIS, J. DAMAK, H. MASMOUDI.
La Tunisie Médicale. Juin-Juillet 2001, vol. 79, n° 6 / 7, 341 – 347.

16/ SENSIBILITE, SPECIFICITE ET VALEUR PRONOSTIQUE DE L’ACE DANS LE CANCER DU COLON-RECTUM : RESULTATS D’UNE SERIE
TUNISIENNE ET REVUE DE LA LITTERATURE.
Y. BEN HADJ HMIDA, N. TAHRI, A. SELLAMI, N. YANGUI, R. JLIDI, M.I BEYROUTI, M.S KRICHEN, H. MASMOUDI.
La Tunisie Médicale.Août-Septembre 2001, vol. 79, n° 8 / 9, 434 – 440.

17/ PEMPHIGUS IS NOT ASSOCIATED WITH ALLOTYPIC MARKERS OF IMMUNOGLOBULIN KAPPA.
M. ZITOUNI, P. MARTEL, G. RAUX, M. BEN AYED, D. GILBERT, P. JOLY, H. TURKI, A. ZAHAF, J. GARGOURI, M. MOKNI, A. BEN OSMAN, H.
MASMOUDI, S. MAKNI, F. TRON.
Genes and Immunity. 2002, n°3, 50 –52.

18/ TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS IS ASSOCIATED WITH DESMOGLEIN 1 GENEPOLYMORPHISM.
M. BEN AYED, P. MARTEL, M. ZITOUNI, D. GILBERT, H. TURKI, M. MOKNI, A. BEN OSMAN, M.R KAMOUN, A. ZAHAF, S. MAKNI, H. MASMOUDI, F. TRON.
Genes and Immunity. 2002, n°3, 378 – 9.

19/ CICLOSPORINE A DANS LE TRAITEMENT DE L’HEPATITE AUTO- IMMUNE DE L’ENFANT : A PROPOS DE 1 CAS.

N. BEN HALIMA, M. CHAABOUNI, A. KARRAY, A. KRICHEN, H. MASMOUDI, R. JLIDI, A. TRIKI.
La Tunisie Médicale. 2002, vol. 80, n°9, 565 – 569.

20/ CRITERES DE CHOIX D’UN AUTOMATE D’IMMUNOANALYSE.
H. MASMOUDI.
Revue Tunisienne de Biologie Clinique. Décembre 2002, n°14, 34 – 40.

21/ APPROCHE POUR L’ETABLISSEMENT DES VALEURS DE REFERENCE (VARIATIONS NORMALES) DANS LA POPULATION TUNISIENNE DE 9 PROTEINES PLASMATIQUES EN SE BASANT SUR LE MATERIAU DE REFERENCE CRM470 DE L’IFCC.
R. ZNAZEN, M. BEN AYED, J. GARGOURI, Y. BEL HADJ HMIDA, M. KASSIS, J. DAMAK, H. MASMOUDI.
La Tunisie médicale. Vol 81, n° 04, 2003 ; 264 – 269.

22/ ANTI-DESMOGLEIN 1 ANTIBODIES IN TUNISIAN HEALTHY SUBJECTS: ARGUMENTS FOR THE ROLE OF ENVIRONMENTAL FACTORS IN OCCURENCE OF TUNISIAN PEMPHIGUS FOLIACEUS.
M. KALLEL-SELLAMI, M. BEN AYED, H. MOUQUET, L. DROUOT, M. ZITOUNI, M. MOKNI, M. CERRUTI, H. TURKI, B. FEZZA, I. MOKHTAR, A.
BEN OSMAN, A. ZAHAF, M.R KAMOUN, P. JOLY, H. MASMOUDI, S. MAKNI, F. TRON, D. GILBERT.
Clinical and experimentalimmunology. 2004 ; 137 : 195 – 200.

23/ DOSAGE DES ANTICORPS ANTI-TRANSGLUTAMINASE DANS LE DIAGNOSTIC DE LA MALADIE CŒLIAQUE DE L’ENFANT : RESULTATS
D’UNE ETUDE PROSPECTIVE SUR CINQ ANS.
L. LAADHAR, N. BOUAZIZ, M. BEN AYED, M. CHAABOUNI, T. BOUDAWARA, M. HACHICHA, R. JLIDI, A. TRIKI, H. MASMOUDI.
Annales de Biologie Clinique. 2004 ; 62 : 431 – 6.

24/ NON REPONSE AU VACCIN DE L’HEPATITE B CHEZ LE PERSONNEL DE SANTE.
S.MAROUEN-JAMOUSSI, D. CHTOUROU, A. KAMMOUN, N. MAHFOUDH, H. MAKNI, H. KARRAY, H. MASMOUDI, A. HAMMAMI, M.L MASMOUDI.
La Tunisie Médicale, Juillet 2004 : 82 (7) : 674 – 8.

25/GAMMAPATHIES MONOCLONALES EN TUNISIE : ANALYSE EPIDEMIOLOGIQUE, IMMUNOCHIMIQUE ET ETIOLOGIQUE D’UNE
SERIE DE 288 CAS.
S. MSEDDI-HDIJI, S. HADDOUK, M. BEN AYED, N. TAHRI, M. ELLOUMI, S. BAKLOUTI, J. HACHICHA, M.S KRICHEN, Z. BAHLOUL, H. MASMOUDI.
PathologieBiologie, 2005 ; 53 : 19 – 25.

26/ CLINICAL SIGNIFICANCE OF ANTI-NUCLEOSOME ANTIBODIES IN TUNISIAN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS.
S. HADDOUK, M. BEN AYED, S. BAKLOUTI, J. HACHICHA, Z. BAHLOUL, H. MASMOUDI.
ClinicalRheumatology, 2005 ; 24 : 219 – 222.

27/AUTO-ANTICORPS DANS LE LUPUS ERYTHEMATEUX SYSTEMIQUE : PROFIL ET CORRELATIONS CLINIQUES.
S. HADDOUK, M. BEN AYED, S. BAKLOUTI, J. HACHICHA, Z. BAHLOUL, H. MASMOUDI.
Pathologie Biologie, 2005 ; 53 : 311 – 317.

28/ GENETIC FACTORS IN PEMPHIGUS.
F. TRON, D. GILBERT, H. MOUQUET, P. JOLY, L. DROUOT, S. MAKNIH. MASMOUDI, D. CHARRON, M. ZITOUNI, P. LOISEAU, M. BEN AYED.
Journal of autoimmunity, 2005 ; 24 : 319 – 328.

29/ PEMPHIGUS ERYTHEMATEUX TUNISIEN ASSOCIE A UN PSORIASIS CHEZ DEUX SŒURS.
A. MASMOUDI, H. HADJ TAIEB, M. BEN AYED, O. ABIDA, H. MAKNI, H. TURKI, H. MASMOUDI, A. ZAHAF.
AnnalesDermatoVenereol, 2006; 133: 181 – 7.

30/ IMMUNOGENETICS OF PEMPHIGUS AN UPDATE. F. TRON, D. GILBERT, P. JOLY, H. MOUQUET, L. DROUOT,
M. BEN AYED, M. SELLAMI, H. MASMOUDI, S. MAKNI.
Autoimmunity, Novembre 2006; 39 (7): 531 – 539.

31/ PN22 R620 W POLYMORPHISM AND PEMPHIGUS.
K. MEJRI, M. KALLEL-SALLEMI, E. PETIT-TEIXEIRA, O. ABIDA, M. HAMDI, M. ZITOUNI, H. TURKI, F. TRON, D. GILBERT, H. MASMOUDI, F. CORNELIS, S. MAKNI.
British Journal of Dermatology, Nov 2007 ; 157 (5) : 1068 – 9.

32/ MARQUEURS DE RISQUE DU DIABETE DE TYPE 1 CHEZ LES APPARENTES AU PREMIER DEGRE DES DIABETIQUES TUNISIENS.
L. LAADHAR, A. GASSARA, N. MAHFOUDH, Y. BEN HADJ HMIDA, T. KAMOUN, M. BEN AYED, N. REKIK, A. MAHFOUDH, A. REBAI, H. MAKNI, M. ABID, M. HACHICHA, H. MASMOUDI.
Annales d’Endocrinologie, Juin 2007, 68 (2 – 3) : 181 – 185.

33/ DERMATOSES BULLEUSES AUTO-IMMUNES MULTIPLES DANS UNE MEME FAMILLE.
A. MASMOUDI, H. CHIKHROUHOU, F. FRIQUI, O. ABIDA, M. BEN AYED, N. LEHYANI, M. AMOURI, H. MASMOUDI, H. MAKNI, A. ZAHAF, H. TURKI.
Annales de Dermatologie et de Vénéreologie, Juin-Juillet 2007 ; 134(6- 7) : 572 -3.

34/ ANTI-DESMOGLEIN-1 ANTIBODIES ARE PREVALENT IN TUNISIAN PATIENTS WITH HYDATIDOSIS AND LEISHMANIASIS.
M. KALLEL-SELLAMI, M. ZITOUNI, W. TOMBARI, M. BEN AYED, O. ABIDA, L. LAADHAR, M. MOKNI, B. FEZAA, H. TURKI, I. MOKHTAR, A.
BEN OSMAN, M.R KAMOUN, P. JOLY, F. TRON, D. GILBERT, H. MASMOUDI, S. MAKNI.
British Journal of Dermatology, Mars 2007 ; 156 (3) : 591 – 3.

35/ PROTECTIVE EFFECT OF 17-ESTRADIOL ON OXIDATIVE STRESSE AND LIVER DYSFUNCTION IN AGED MALE RATS.
K. HAMDEN, S. CARREAU, F. ELLOUZ, H. MASMOUDI, A. EL FEKI.
J. Physiol. Biochem., 2007 ; 63 (3) : 195 – 202.

36/ TUNISIAN PEMPHIGUS FOLIACEUS WITH ANTI-DESMOGLEIN3 ANTIBODY.
A. MASMOUDI, S. BRICAULT, H. CHIKHROUHOU, A. ZAHAF, H. TURKI, O. ABIDA, M. BEN AYED, H. MASMOUDI, D. GILBERT, F. TRON, P. JOLY.
Annales de Dermatologie Vénérologie, Janvier 2008 ; 135 (1) : 69 – 70.

37/ PROTECTIVE EFFECTS OF PEGANUMHARMALA EXTRACTS ON THIOUREA-INDUCED DISEASES IN ADULT MALE RAT.
Kh. HAMDEN, H. MASMOUDI, F. ELLOUZ, A. ELFEKI, S. CARREAU.
J. Environ. Biol., 2008 ; 29 (1), 73 – 77.

38/ COMBINED VITAMINS (C AND E) AND INSULIN IMPROVE OXIDATIVE STRESS AND PANCREATIC AND HEPATIC INJURY IN
ALLOXAN DIABETIC RATS.

Kh. HAMDEN, M.A. BOUJBIHA, H. MASMOUDI, F. ELLOUZ, F. MAKNI- AYADI, K. JAMOUSSI, A. ELFEKI.

Biomedicine&Pharmacotherapy, 2008 ; 1 – 5.

39/ ASSOCIATION DIABETE DE TYPE 1 ET MALADIE COELIAQUE CHEZ L’ENFANT.
H. ALOULOU, T. KAMMOUN, M. BEN AYED, H. MASMOUDI, M. HACHICHA.
Journal de Pédiatrie et de puériculture, 2008 ; 21 : 37 – 43.

40/ VASCULARITE A ANTICORPS ANTICYTOPLASME DES POLYNUCLEAIRES NEUTROPHILES INDUITE PAR LE BENZYLTHIOURACILE : ETUDE DE TROIS OBSERVATIONSET REVUE DE LA LITTERATURE.
M. FRIGUI, M. KECHAOU, S. HADDOUK, A. MASMOUDI, N. KADDOUR, H. MASMOUDI, H. TURKI, Z. BAHLOUL.
Annalesd’Endocrinologie, Septembre 2008 ; 69 : 517 – 522.

41/ POSITIVE EFFECTS OF GREEN TEA ON HEPATIC DYSFUNCTION, LIPID PEROXIDATION AND ANTIOXIDANT DEFENCE DEPLETION
INDUCED BY CADMIUM.
Kh. HAMDEN, S. CARREAU, F. AYADI-MAKNI, H. MASMOUDI, A. EL FEKI.
Biol Res, 2008 ; 41 : 331 – 339.

42/ LES AUTO-ANTICORPS PANCREATIQUES CHEZ LES ENFANTS DIABETIQUES DE PRIMO-DECOUVERTE DE TYPE 1 EN TUNISIE.
R. FAKHFAKH, S. HADDOUK, Y. BEN HADJ HMIDA, T. KAMOUN, M. BEN AYED, M. HACHICHA, H. MASMOUDI.
Pathologie Biologie, 2008 ; 56 (3) : 130 – 132.

43/ SFP-P052 – PÉDIATRIE GÉNÉRALE ET SOCIALE – PROFIL ÉPIDÉMIOLOGIQUE DU DIABÈTE DE TYPE 1 ÉTUDE PROSPECTIVE DE
184 CAS.
T. KAMOUN, A. BEN THABET, H. ALOULOU, Y. BEN HADJ HMIDA, M. BEN AYED, H. MASMOUDI, M. HACHICHA.
Archives de Pédiatrie, Juin 2008 ; volume 15, Issue 5 : 959 – 960.

44/THERAPEUTIC EFFECT OF PHYTOECDYSTEROIDS RICH EXTRACT FROM AJUGA IVA ON ALLOXAN INDUCED DIABETIC RATS LIVER,
KIDNEY AND PANCREAS.
Kh. HAMDEN, F. AYADI, K. JAMOUSSI, H. MASMOUDI, A. EL FEKI.
Biofactors, 2008 ; 33(3) : 165 – 75.

45/ COMBINED VITAMINS (C AND E) AND INSULIN IMPROVE OXIDATIVE STRESS AND PANCREATIC AND HEPATIC INJURY IN5 ALLOXAN DIABETIC RATS.
Kh. HAMDEN, M.A BOUJBIHA, H. MASMOUDI, F. AYADI-MAKNI, K. JAMOUSSI, A. EL FEKI.
Biomedicine & Pharmacotherapy, 2009 ; 63 : 95 – 99.

46/ CLINICAL AND DIAGNOSTIC VALUE OF RIBOSOMAL P AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS.
S. HADDOUK, S. MARZOUK, M. JALLOULI, H. FOURATI, M. FRIGUI, Y. BEN HAJ HMIDA, F. KOUBAA, W. SELLAMI, S. BAKLOUTI, J. HACHICHA, Z. BAHLOUL, H. MASMOUDI.
Rheumatology, 2009 ; 48 : 953 – 957.

47/ ANTI-DESMOGLEIN 1 ANTIBODIES IN HEALTHY SUBJECTS IN ENDEMIC AND NON-ENDEMIC AREAS FROM TUNISIA.
O. ABIDA, M. KALLEL-SALLEMI, P. JOLY, M. BEN AYED, M. ZITOUNI, A. MASMOUDI, M. MOKNI, B. FEZAA, A. BEN OSMAN, MR. KAMOUN, D.
GILBERT, H. TURKI, F. TRON, H. MASMOUDI , S. MAKNI.
Journal of the European Academy of Dermatology and Venereology, 2009 ; 23 : 1073 – 1078.

48/ TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS IS ASSOCIATED WITH HLA-DR3 GENE: ANTI-DESMOGLEIN 1 ANTIBODY POSITIVE HEALTHY SUBJECTS BEAR PROTECTIVE ALLELES.
O. ABIDA, M. ZITOUNI, M. KALLEL-SALLEMI, N. MAHFOUDH, A. KAMOUN, M. BEN AYED, A. MASMOUDI, M. MOKNI, B. FEZAA, A. BEN
OSMAN, MR. KAMOUN, H. TURKI, H. MAKNI, D. GILBERT, P. JOLY, F. TRON, S. MAKNI, , H. MASMOUDI.
British Journal of Dermatology, 2009 ; 161(3) : 522 – 7.

49/ THE FAMILIAL FEATURE OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS
O. ABIDA , A. MASMOUDI, A. REBAÏ, M. BEN AYED, N. MAHFOUDH, M. KALLEL-SELLAMI, S. MAKNI, P. JOLY, D. GILBERT, H. MAKNI, F. TRON, H. MASMOUDI,H. TURKI.
British Journal of Dermatology, 2009; 161(4): 951 – 3.

50/ Inhibitory effect of Estrogens, Phytoestrogens and Caloric Restriction on  Oxidative Stress and Hepato-toxicity in Aged Rats.
Kh. HAMDEN, S. CARREAU, F. AYADI, H. MASMOUDI, A. ELFEKI.
Biomedical and environmental sciences, 2009; 22(5): 381 – 7.

51/ TRAF1/C5 polymorphism is not associated with pemphigus.
K. MEJRI, H. MBAREK, M. KALLEL-SELLAMI, E. PETIT-TEIXEIRA, Y. ZERZERI, O. ABIDA, M. ZITOUNI, M. BEN AYED, M. MOKNI, B. FEZZA, H.
TURKI, F. TRON, D. GILBERT, H. MASMOUDI, B. PRUM, F. CORNELIS, S. MAKNI.
British Journal of Dermatology, Juin 2009 ; 160 (6) : 1348 – 50.

52/ MALADIE D’ADDISON AU COURS DE LA POLYENDOCRINOPATHIE AUTO-IMMUNE TYPE II : ASPECTS ÉPIDÉMIOLOGIQUES, CLINIQUES ET IMMUNOLOGIQUES.
F. MNIF, S. BEN SALAH, H. FOURATI, N. REKIK, N. CHARFI, H. MASMOUDI, M. ABID.
Diabetes & Metabolism, Mars 2009 ; 35 supplément1, P. A44.

53/ LIPID PEROXIDATION AND ANTI-OXIDANT SYSTEM IN THE TUMOR AND IN THE BLOOD OF PATIENTS WITH NASOPHARYNGEAL CARCINOMA.
B. GARGOURI, S. LASSOUED, W. AYADI, H. KARRAY, H. MASMOUDI, N. MOKNI, H. ATTIA, AE EL FEKI.
Biol Trace Elem Research, Dec 2009 ; 132 (1-3) : 27 – 34.

54/ ENHANCED REACTIVITY TO MALONDIALDEHYDE-MODIFIED PROTEINS BY SYSTEMIC LUPUS ERYTHEMATOSUS AUTOANTIBODIES.
R. BEN MANSOUR, S. LASSOUED, A. ELGAIED, S. HADDOUK, S. MARZOUK, Z. BAHLOUL, H. MASMOUDI, H. ATTIA, MS AIFA, F. FAKHFAKH.
Scand J. Rheumatol, Mai 2010 ; 39(3) : 247-53.

55/ VALEUR DIAGNOSTIQUE ET SIGNIFICATION CLINIQUE DES MARQUEURS SEROLOGIQUES CHEZ LES PATIENTS TUNISIENS ATTEINTS DE MALADIES INFLAMMATOIRES DE L’INTESTIN.
D. BOUZID, S. HADDOUK, A. AMOURI, Y. BEN HAJ HMIDA, S. BOUKTHIR, M. BEN AYED, N. TAHRI, H. MASMOUDI.
Annales de Biologie Clinique, Septembre-Octobre 2010 ; 68(5) : 577 – 83.

56/ A COMPARATIVE STUDY OF THE OXIDATIVE PROFILE IN GRAVES’DISEASE, HASHIMOTO’S THYROIDITIS, AND PAPILLARY THYROID CANCER.
S. LASSOUED, M. MSEDDI, F. MNIF, M. ABID, F. GUERMAZI, H. MASMOUDI, A. EL FEKI, H. ATTIA.
Biol Trace ElemRes. Décembre 2010 ; 138 (1-3) : 107 – 15.

57/ Systemic sclerosis in a patient with pityriasisrubra pilaris.
F. FRIKHA, M. FRIGUI, H. MASMOUDI, H. TURKI, Z. BAHLOUL.
Pan African Medical Journal, Août 2010 ; volume 6, Issue 6.

58/ Immunomodulatory, beta-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes.
K. HAMDEN, H. MASMOUDI, S. CARREAU, A. ELFEKI.
Immunopharmacol Immunotoxicol, Septembre 2010 ; 32(3) : 437-45.

59/ Dermatomyosites et polymyosites du sud tunisien : étude de 67 cas.
N. KADDOUR, M. FRIGUI, S. MARZOUK, S. HADDOUK, M. MSEDDI, M. BEN AYED, H. MASMOUDI, H. TURKI, T. BOUDAOUARA, C. MHIRI, Z. BAHLOUL.
Revue Tunisienne de la Santé Militaire, Décembre 2010 : 12 : 236 – 42.

60/ ANTI-NUCLEOSOME ANTIBODIES MAY PREDICT LUPUS NEPHRITIS AND SEVERITY OF DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS.
S. HADDOUK, H. HACHICHA, S. MARZOUK, H. FOURATI, M. BEN HMIDA, S. BAKLOUTI, J. H ACHICHA, Z. BAHLOUL, H. MASMOUDI.
Indian Journal of Rheumatology, Décembre 2010, volume 5, n°4 ; pp. 165 – 170.

61/ LA SCLÉROMYOSITE : À PROPOS DE 8 OBSERVATIONS.
M. SNOUSSI, F. FRIKHA, M. FRIGUI, N. KADDOUR, F. MAAZOUN, R. BEN SALAH, F. NJAH, R. ALLALA, S. MARZOUK, M. JALLOULI, H. MASMOUDI, Z. BAHLOUL.
La revue de Médecine Interne, 2010 ; S404 – S501.

62/ HLA-DRB1/DQB1 susceptibility for autoimmune polyglandular syndrome type II and III in south of Tunisia.
H. FOURATI, N. MAHFOUDH, O. ABIDA, A. KAMMOUN, F. MNIF, S. HADDOUK, M. BEN AYED, Y. BEN HADJ HMIDA, N. REKIK, M. ABID, H.
MAKNI, H. MASMOUDI.
Ann Endocrinol (Paris). 2011 Jun ; 72(3) : 232-8.

63/SPECTRUM OF AUTOANTIBODIES OTHER THAN ANTI-DESMOGLEIN IN PEMPHIGUS PATIENTS.
K. MEJRI, O. ABIDA, M. KALLEL-SELLAMI, S. HADDOUK, L. LAADHAR, I. ZARRAA, M. BEN AYED, M. ZITOUNI, M. MOKNI, H. LAHMAR, B. FEZAA, H. TURKI, F. TRON, H. MASMOUDI, S. MAKNI.
J. EurAcadDermatolVenereol, 2011 Jul ; 25(7) : 774-81.

64/ SYSTEMIC LUPUS ERYTHEMATOSUS-MYOSITIS OVERLAP SYNDROME: REPORT OF 6 CASES.
F. MAAZOUN, F. FRIKHA, M. SNOUSSI, N. KADDOUR, H. MASMOUDI, Z. BAHLOUL.
Clinics and Practice. 2011 ; volume 1 : e89.

65/ CONTRIBUTION OF IMMUNOFLUORESCENCE TO IDENTIFICATION AND CHARACTERIZATION OF ANTINEUTROPHIL CYTOPLASMIC
ANTIBODIES IN INFLAMMATORY BOWEL DISEASE.
D. BOUZID, S. HADDOUK, A. AMOURI, Y. BEN HADJ HMIDA, N. TAHRI, H. MASMOUDI.
Indian Journal of Gastroenterology. 2011 Sep ; 30 (5) : 229 – 32.

66/ THE CREM GENE IS INVOLVED IN GENETIC PREDISPOSITION TO INFLAMMATORY BOWEL DISEASE IN THE TUNISIAN POPULATION.
D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, S. HADDOUK, M. BEN AYED, N. TAHRI, C. PENHA-GONÇALVES, H. MASMOUDI.
Human Immunology, December 2011 ; 72(12) : 1204 – 9.

67/ LA VACCINATION ANTI-HÉPATITE B AUX ÉTABLISSEMENTS PUBLICS DE SANTÉ DE SFAX (TUNISIE).
I. GARGOURI, K. JMAL-HAMMAMI, A. SOBASZEK, H. MASMOUDI, H. KARRAY, A. HAMMAMI, P. FRIMAT, M.L MASMOUDI.
Archives des maladies professionnelles et de l’environnement. 2011 ; 72 : 36 – 43.

68/ CLINICAL IMPLICATIONS AND PROGNOSTIC SIGNIFICANCE OF THROMBOCYTOPENIA IN TUNISIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
M. JALLOULI, M. FRIGUI, S. MARZOUK, M. SNOUSSI, M. KECHAOU, N. KADDOUR, H. MASMOUDI, M. ELLOUMI, Z. BAHLOUL.
Lupus, 2012 ; 21(6) : 682 – 7.

69/ NON-HLA AUTOIMMUNITY GENETIC FACTORS CONTRIBUTING TO AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE II IN TUNISIAN
PATIENTS.
H. FOURATI, D. BOUZID, O. ABIDA, N. KHARRAT, F. MNIF, S. HADDOUK, C. FESEL, J. COSTA, M. BEN AYED, M. ABID, A. REBAI, C. PENHA-
GONCALVES, H. MASMOUDI.

Human Immunology, 2012 ; 73 : 740 – 746.

70/ ASSOCIATION OF THE RAVER2 GENE WITH INCREASED SUSCEPTIBILITY FOR ULCERATIVE COLITIS.
D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, S. HADDOUK, M. BEN AYED, N. TAHRI, C. PENHA-GONCALVES, H. MASMOUDI.
Hum Immunol, 2012 ; 73(7) : 732 – 5.

71/ PREVALENCE ET VALEUR DIAGNOSTIQUE DES ANTI-NUCLEAIRESDE SPECIFICITE ANTIGENIQUE INDETERMINEE : ETUDE RETROSPECTIVE A PROPOS D’UNE SERIE DE 90 PATIENTS.

S. FEKI, F. FRIKHA, Y. BEN HADJ HMIDA, S. ABED, M. BEN AYED, H. TURKI, J. HACHICHA, S. BAKLOUTI, Z. BAHLOUL, H. MASMOUDI.
La Revue de Médecine Interne, 2012, volume 33, Issue 9, P 475 – 486.

72/ REPLICATION OF IDENTIFIED INFLAMMATORY BOWEL DISEASES GENETIC ASSOCIATIONS: A CASE –CONTROL STUDY IN THE TUNISIAN POPULATION.
D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, N. TAHRI, C. PENHA-GONÇALVES, H. MASMOUDI.
Journal of Clinical & Cellular Immunology, 2012, doi.org/10.4372/2155-9899. S10-001.

73/ PREGNANCY IN DERMATOMYOSITIS AND POLYMYOSITIS.
N. KADDOUR, M. SNOUSSI, S. MARZOUK, F. FRIKHA, M. JALLOULI, M. FRIGUI, H. MASMOUDI, M. GUERMAZI, Z. BAHLOUL.
La TunisieMédicale, 2012 ; 90(8) : 606-12.

74/ INFLAMMATORY BOWEL DISEASE : SUSCEPTIBILITY AND DISEASE HETEROGENEITY REVEALED BY HUMAN LEUKOCYTE ANTIGEN GENOTYPING.
D. BOUZID, A. KAMMOUN, A. AMOURI, N. MAHFOUDH, S. HADDOUK, N. TAHRI, H. MAKNI, H. MASMOUDI.
Genetic Testing and Molecular Biomarkers, 2012; 16(6): 482 – 7

75/ CATALASE AND LIPID PEROXIDATION VALUES IN SERUM OF TUNISIAN PATIENTS WITH PEMPHIGUS VULGARIS AND FOLIACEUS.
O. ABIDA, R. BEN MANSOUR, B. GARGOURI, M. BEN AYED, A. MASMOUDI, H. TURKI, H. MASMOUDI, S. LASSOUED.
Biological Trace Element Research, Dec 2012 ; 150 (1 – 3) : 74 – 80.

76/ LE SYNDROME DES ANTISYNTHETASES : A PROPOS DE QUATRE OBSERVATIONS ET REVUE DE LA LITTERATURE.
F. FRIKHA, N. SAIDI, M. SNOUSSI, R. BEN SALAH, M. BEN AYED, E. DAOUD, Y. HENTATI, S. MAKNI, Z. MNIF, T. BOUDAWARA, H. MASMOUDI, Z. BAHLOUL.
Revue de Pneumologie clinique, 2012, Dec ; 68 (6) : 351 – 60.

77/ GENETIC FACTORS CONTRIBUTING TO SYSTEMIC LUPUS ERYTHEMATOSUS IN TUNISIAN PATIENTS.
H. FOURATI, D. BOUZID, O. ABIDA, N. KHARRAT, S. MARZOUK, S. HADDOUK, C. FESEL, J. COSTA, M. BEN AYED, Z. BAHLOUL, C. PENHA-
CONCALVES, A. REBAI, H. MASMOUDI.

Journal of Clinical and Cellular Immunology, 2012 ; 3 : 4.

78/ POLYMORPHISMS OF HLA MICROSATELLITE MARKER IN TUNISIAN PEMPHIGUS FOLIACEUS.

O. ABIDA, N. MAHFOUDH, A. KAMMOUN, L. GADDOUR, F. HAKIM, A. TOUMI, A. MASMOUDI, M. BEN AYED, H. TURKI, H. MASMOUDI, H. MAKNI.
Human Immunology 2013 Jan ; 74(1) : 104-9.

79/ BIOMARKERS OF OXIDATIVE STRESS IN EPIDERMIS OF TUNISIAN PEMPHIGUS FOLIACEUS PATIENTS.
O. ABIDA, B. GARGOURI, R. BEN MANSOUR, M. MSEDDI-DJEMAL, A. MASMOUDI, M. BEN AYED, M. ABDELMOULA, H. TURKI, S. LASSOUED,
H. MASMOUDI.
Journal of the European Academy of Dermatology and Venereology, Mars 2013 ;27 (3) : e 271 – 5.

80/ ASSOCIATION OF ZAP70 AND PTPN6, BUT NOT BANK1 OR CLEC2D,WITH INFLAMMATORY BOWEL DISEASE IN THE TUNISIAN POPULATION.
D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, S. HADDOUK, M. BEN AYED, N. TAHRI, C. PENHA GONCALVES, H. MASMOUDI.
Genetic Testing and Molecular Biomarkers. 2013 Apr ; 17(4) : 321-6.

81/ CYTOKINE GENE POLYMORPHISMS IN TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS: A POSSIBLE ROLE OF IL-4 VARIANTS.
A. TOUMI, O. ABIDA, M. BEN AYED, A. MASMOUDI, H. TURKI, H. MASMOUDI.
Human Immunology, 2013 May ; 74(5) : 658-65.

82/ AUTOIMMUNE REACTIVITY AGAINST PRECURSOR FORM OF DESMOGLEIN 1 IN HEALTHY TUNISIANS IN THE AREA OF ENDEMIC
PEMPHIGUS FOLIACEUS.
A. TOUMI, MA. SALEH, J. YAMAGAMI, O. ABIDA, M. KALLEL, A. MASMOUDI, S. MAKNI, H. TURKI, T. HACHIYA, K. KURODA, JR. STANLEY, H. MASMOUDI, M. AMAGAI.
Journal of Dermatological Science, 2013 Apr ; 70(1) : 19-25.

83/ SECRETED RECOMBINANT P53 PROTEIN FROM PICHIA PASTORIS IS A USEFUL ANTIGEN FOR DETECTION OF SERUM P53: AUTOANTIBODY IN PATIENTS WITH ADVANCED COLORECTAL ADENOCARCINOMA.
S. ABDELMOULA-SOUISSI, N. ZOUARI, I. MILADI-ABDENADHER, O. YAICH-KOLSI, I. AYADI-MASMOUDI, A. KHABIR, H. MASMOUDI, M. FRIKHA, R. MOKDAD-GARGOURI.
Molecular Biology Reports, 2013 May;40(5):3865-72.

84/ OXIDATIVE STRESS MARKERS IN INTESTINAL MUCOSA OF TUNISIAN INFLAMMATORY BOWEL DISEASES PATIENTS.

D. BOUZID, B. GARGOURI, RB. MANSOUR, A. AMOURI, N. TAHRI, S. LASSOUED, H. MASMOUDI.
Saudi Journal of Gastroenterology, 2013 May-Jun ; 19 (3) : 131-5.

85/ ASSOCIATION STUDY OF MICA-TM POLYMORPHISM WITH INFLAMMATORY BOWEL DISEASE IN SOUTH TUNISIAN POPULATION.
A. KAMOUN, D. BOUZID, N. MAHFOUDH, A. AMOURI, L. GADDOUR, F. HAKIM, N. TAHRI, H. MASMOUDI, H. MAKNI.
Genetic Testing and Molecular Biomarkers, 2013 Aug; 17 (8) : 615-9.

86/ POLYMORPHISMS IN THE IL2RA AND IL2RB GENES IN INFLAMMATORY BOWEL DISEASE RISK.
D. BOUZID, A. AMOURI, H. FOURATI, I. MARQUES, O. ABIDA, N. TAHRI, CP. GONCALVES, H. MASMOUDI.
Genetic Testing and Molecular Biomarkers, 2013 Nov ; 17 (11) : 833 – 9.

87/POTENTIAL ROLE OF TLR LIGAND IN AETHIOPATHOGENESIS OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.
O. ABIDA, D. BOUZID, S. KRICHEN-MAKNI, N. KHARRAT, A. MASMOUDI, M. ABDELMOULA, M. BEN AYED, H. TURKI, T. SELLAMI-BOUDAWARA, H. MASMOUDI.
Biochemistry & Physiology, 2013, 2: 117.

88/ CONTRIBUTION OF PTPN22, CD28, CTLA-4 AND ZAP-70 VARIANTS TO THE RISK OF TYPE 1 DIABETES IN TUNISIANS.
F. ZOUIDI, M. STAYOUSSEF, D. BOUZID, H. FOURATI, O. ABIDA, M. BEN AYED, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H.
MASMOUDI.
Gene. 2014 Jan 1;533(1):420-6.

89/ ASSOCIATION OF BANK-1 AND CYTOKINE GENE POLYMORPHISMS WITH TYPE 1 DIABETES IN TUNISIA.
F. ZOUIDI, M. STAYOUSSEF, D. BOUZID, H. FOURATI, O. ABIDA, J. COSTA, M. BEN AYED, R. FAKHFAKH, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.
Gene. 2014 Feb 25;536(2):296-301.

90/ ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY AND RHEUMATOID FACTOR IN SOUTH TUNISIAN PATIENTS WITH RHEUMATOID ARTHRITIS: ASSOCIATION WITH DISEASE ACTIVITY AND severity.
MB. HAMAD, S. MARZOUK, N. KADDOUR, H. MASMOUDI, F. FAKHFAKH, A. REBAI, Z. BAHLOUL, A. MAALEJ.
Journal of Clinical Laboratory Analysis, 2014 Jan;28(1):21-6.

91/ EFFET D’UN PROTOCOLE CYCLOPHOSPHAMIDE A INTERVALLE COURT AU COURS DE LA NEPHROPATHIE LUPIQUE.
H. FERIANI, I. AGREBI, K. KAMMOUN, M. KHARRAT, S. MAKNI, A. CHARFI, S. YAICH, F. JARRAYA, Y. CHAABOUNI, H. MASMOUDI, T.
BOUDAWARA, J. HACHICHA.
16ème Réunion commune de la Société de Néphrologie et de la Société Francophone de dialyse. Néphrologie et Thérapeutique. 2014 ; (10) : 331 – 378.

92/ CAUSES AND OUTCOME OF HOSPITALISATIONS IN TUNISIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
MOEZ JALLOULI , H. HRIZ , Y. CHERIF , S. MARZOUK , M. SNOUSSI,F. FRIKHA, R. BEN SALAH , H. MASMOUDI, Z. BAHLOUL .
Lupus Science &Medicine, 2014 Jun 5; 1 (1).

93/ AUTOIMMUNE DISEASES ASSOCIATION STUDYWITH THE KIAA1109-IL2-IL21 REGION IN A TUNISIAN POPULATION.
D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, N. TAHRI, C. PENHA-GONCALVES, H. MASMOUDI.
Molecular Biology Reports, 2014 Nov;41(11):7133-9.

94/ LATE-ONSET PRIMARY ANTIPHOSPHOLIPID SYNDOROME IN THE ELDERLY: A REPORT OF SEVEN CASES.
YOSRA CHERIF, M. JALLOULI, H. HRIZ, R. GOUIAA, S. MARZOUK, M. SNOUSSI, F. FRIKHA, H. MASMOUDI, Z. BAHLOUL.
Int. J. Rheum Dis, 2015 Jan ; 18 (1) : 103-7.

95/ NEONATAL LUPUS AND MATERNOFETAL TRANSMISSION OF ANTI-SSA/RO AND ANTI-SSB/LA ANTIBODIES.

S. FEKI, A. TURKI, F. FRIKHA, H. HACHICHA, L. WALHA, A. GARGOURI, Z. BAHLOUL, H. MASMOUDI.
Archives de Pédiatrie, 2015 Feb;22(2):154-9. French.

96/ ASSOCIATION OF TCR/CD3, PTPN22, CD28 AND ZAP70 GENE POLYMORPHISMS WITH TYPE 1 DIABETES RISK IN TUNISIAN
POPULATION: FAMILY BASED ASSOCIATION STUDY”
F. ZOUIDI, D. BOUZID, H. FOURATI, M. STAYOUSSEF, O. ABIDA, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.
Immunology Letters, 2015 Jan ; 163 (1) : 1 – 7.

97/ LUPUS ERYTHEMATEUX SYSTEMIQUE A DEBUT PEDIATRIQUE : A PROPOS D’UN CAS.
SANA KHLIF, H. HACHICHA, F. FRIKHA, S. FEKI, Z. BAHLOUL, H. MASMOUDI.

PanAfrican Medical Journal, 2015 ; 20 ; 25.

98/ IS THERE ANY RELATIONSHIP BETWEEN POLYMORPHISM OF HEAT SHOCK PROTEIN 70 GENES AND PEMPHIGUS FOLIACEUS?
Amina TOUMI, O. ABIDA, M. BEN AYED, A. MASMOUDI, H. TURKI, H. MASMOUDI.
Immunology Letters, 2015 ; 164 : 94 – 99.

99/ NOVEL AND RECURRENT AID MUTATIONS UNDERLIE PREVALENT AUTOSOMAL RECESSIVE FORM OF HIGM IN CONSANGUINEOUS
PATIENTS.
H. OUADANI, I. BEN-MUSTAPHA, M. BEN-ALI, L. BEN-KHEMIS, B. LARGUÈCHE, R. BOUSSOFFARA, S. MAALEJ, I. FETNI, S. HASSAYOUN, A. MAHFOUDH, F. MELLOULI, S. YALAOUI, H. MASMOUDI, M. BEJAOUI, MR. BARBOUCHE.
Immunogenetics. 2016 Jan;68(1):19 – 28. doi: 10.1007/s00251-015-0878-6. Epub 2015 Nov 6.

100/ ELEVATED PROLACTIN LEVELS IN PATIENTS WITH PEMPHIGUS FOLIACEUS.
AMINA TOUMI, K. CHAABOUNI, O. ABIDA, H. HACHICHA, M. BEN AYED, A. MASMOUDI, H. TURKI, F. AYEDI, H. MASMOUDI.
Herald Scholary Open Access Journal of Clinical Dermatology and Therapy, 2016, 3: 017.

101/ ASSOCIATION BETWEEN THE IL2RA POLYMORPHISM AND TYPE 1 DIABETES RISK: FAMILY BASED ASSOCIATION STUDY.
Ferjeni ZOUIDI, D. BOUZID, H. FOURATI, R. FAKHFAKH, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.
Meta Gene, December 2016, 10 : 118 – 122.

102/ AUTOANTIBODIES DIABETES AND MICRONUTRIMENTS IN TYPE 1 DIABETICS AND SIBLINGS OF ABIDJAN DISTRICT, IVORY COAST.
CHIAYÉ CLAIRE ANTOINETTE YAPO-CREZOIT, AÏSSÉ FLORENCE JUDITH TRÉBISSOU, FRANCIS ADOU YAPO, SANA KHLIF, AMINA LAHYANI, KOUMBA AGBO-SOUMAHORO, FATMA MAKNI AYEDI, HATEM MASMOUDI, JOSEPH ALLICO DJAMAN, MIREILLE DOSSO.
European Journal of Pharmaceutical and Medical Research, 2016,3(11), 637-643

103/ ACTIVATION INDUCED CYTIDINE DEAMINASE MUTANT (AID-HIS130PRO) FROM HYPER IGM 2 PATIENT RETAINED MUTAGENIC

ACTIVITY ON SHM ARTIFICIAL SUBSTRATE.
Hanène OUADANI, I. BEN-MUSTAPHA, M. BEN-ALI, B. LARGUÈCHE, T. JOVANIC, S. GARCIA, B. ARCANGIOLI, H. ELLOUMI-ZGHAL, D. FATHALLAH, M. HACHICHA, H. MASMOUDI, F. ROUGEON, MR. BARBOUCHE.
Molecular immunology, Nov 2016, 4 ; 79 : 77 – 82.

104/ CREM VARIANT RS17583959 CONFERRED SUSCEPTIBILITY TO T1D RISK IN THE TUNISIAN FAMILIES.
Ferjeni ZOUIDI, D. BOUZID, H. FOURATI, R. FAKHFAKH, Th. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.
Immunology Letters, Jan. 2017 ;181:1-5.

105/ DIFFERENTIAL REACTIVE OXYGEN SPECIES PRODUCTION OF NEUTROPHILS AND THEIR OXIDATIVE DAMAGE IN PATIENTS WITH ACTIVE AND INACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS.
NesrineELLOUMI, RB. MANSOUR, S. MARZOUK, M. MSEDDI, R. FAKHFAKH, B. GARGOURI, H. MASMOUDI, S. LASSOUED.
Immunology Letters, Apr. 2017, 3 ; 184 : 1 – 6.

106/ ROLE OF FOXP3 GENE POLYMORPHISM IN THE SUSCEPTIBILITY TO TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.
Mariem BEN JMAA, O. ABIDA, E. BAHLOUL, A. TOUMI, S. KHLIF, R. FAKHFAKH, N. ELLOUMI, K. SALLEMI, A. MASMOUDI, H. TURKI, H. MASMOUDI.
Immunology Letters, Apr. 2017, 16 ; 184 : 105 – 111.

107/ THE INCREASED EXPRESSION OF TOLL-LIKE RECEPTOR 4 IN RENAL AND SKIN LESIONS IN LUPUS ERYTHEMATOSUS.
Nesrine ELLOUMI, R. FAKHFAKH, L. AYADI, K. SELLAMI, O. ABIDA, M. BEN JMAA, T. SELLAMI, K. KAMMOUN, H. MASMOUDI.
Journal of HistochemistryCytochemistry, Jul 2017 ; 65 (7) : 389 – 398.

108/ GENETIC ASSOCIATION AND PHENOTYPIC CORRELATION OF TLR4 BUT NOT NOD2 VARIANTS WITH TUNISIAN INFLAMMATORY BOWEL DISEASE.
Sawsan FEKI, D. BOUZID, O. ABIDA, L. CHTOUROU, N. ELLOUMI, A. TOUMI, H. HACHICHA, A. AMOURI, N. TAHRI, H. MASMOUDI.
Journal of Digestive Diseases, Nov 2017 ; 18(11) : 625 – 633.

109/ RELEVANT GENETIC POLYMORPHISMS AND KIDNEY EXPRESSION OF TOLL-LIKE RECEPTOR TLR5 AND TLR9 IN LUPUS NEPHRITIS.
NesrineELLOUMI, R. FAKHFAKH, O. ABIDA, L. AYADI, S. MARZOUK, H. HACHICHA, M. FOURATI, Z. BAHLOUL, MN. MHIRI, K. KAMMOUN, H. MASMOUDI.
Clinical & Experimental Immunology, Dec 2017 ; 190(3) : 328 – 339.

110/ POSITIVITE DES ANTICORPS ANTI-CYTOPLASME DES POLYNUCLEAIRES NEUTROPHILES CHEZ L’ENFANT : PREVALENCE ET
ETIOLOGIES.
Améni JERBI, S. FEKI, S. BEN AMEUR, H. HACHICHA, L. GARGOURI, T. KAMOUN, A. MAHFOUDH, M. HACHICHA, H. MASMOUDI.
Annales de Biologie Clinique (Paris), Janv 2018 ; 76(1) : 68 – 74.

111/ HUMAN LEUCOCYTE ANTIGENS-DRB1*03 IS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-SSB PRODUCTION IN
SOUTH TUNISIA.
Hend HACHICHA, A. KAMMOUN, N. MAHFOUDH, S. MARZOUK, S. FEKI, R. FAKHFAKH, H. FOURATI, S. HADDOUK, F. FRIKHA, L. GADDOUR, F. HAKIM, Z. BAHLOUL, H. MAKNI, H. MASMOUDI.
International Journal of Health Sciences, Vol. 12, Issue 1 (January – February 2018).

112/ HLA CLASS III: A SUSCEPTIBILITY REGION TO SYSTEMIC LUPUS ERYTHEMATOSUS IN TUNISIAN POPULATION.
Hend HACHICHA, N. MAHFOUDH, H. FOURATI, N. ELLOUMI, S. MARZOUK, S. FEKI, R. FAKHFAKH, F. FRIKHA, A. AYADI, A.MAATOUG, L. GADDOUR, F. HAKIM, Z. BAHLOUL, H. MAKNI, H. MASMOUDI, A. KAMMOUN
PLoS One. 2018 Jun 18 ; 13(6) : e0198549. doi: 10.1371/journal.pone.0198549. eCollection 2018.

113/ INVOLVEMENT OF THE IL23/TH17 PATHWAY IN THE PATHOGENESIS OF TUNISIAN PEMPHIGUS FOLIACEUS.
Mariem BEN JMAA, O. ABIDA, R. FAKHFAKH, E. BAHLOUL, Kh. SELLAMI, L. GADDOUR, N. ELLOUMI, M. BEN AYED, A. MASMOUDI, M. DHOUIB, M. ABDELMOULA, N. MAHFOUDH, H. MAKNI, H. TURKI, H. MASMOUDI
Mediators of Inflammation, 2018 Jul 12 ; 2018 : 8206983. Doi : 10.1155/2018/8206983. eCollection 2018.

114/ PROFIL EPIDEMIOLOGIQUE, CLINIQUE ET VALEUR DIAGNOSTIQUE DES ANTICORPS ANTI-JO1 (ANTICORPS ANTI-AMINOACYL-T-RNA-SYNTHETASES) ETUDE RETROSPECTIVE A PROPOS D’UNE SERIE DE 22

PATIENTS.
Faten FRIKHA, H. HACHICHA, I. JALLOULI, M. SNOUSSI, R. BEN SAAH, H. MASMOUDI, Z. BAHLOUL.
Revue Médicale Internationale Maghrébine, n° 251, Juillet-Août 2018.

115/ THE INTRATHECAL POLYSPECIFIC ANTIVIRAL IMMUNE RESPONSE (MRZ REACTION): A POTENTIAL CEREBROSPINAL FLUID MARKER FOR MULTIPLE SCLEROSIS DIAGNOSIS.

Sawsan FEKI, S. GARGOURI, S. MEJDOUB, M. DAMMAK, H. HACHICHA, O. HADIJI, L. FEKI, A. HAMMAMI, C. MHIRI, H. KARRAY, H. MASMOUDI.
Journal of Neuroimmunology, 2018 Aug 15 ; 321 : 66 – 71.

116/ PEMPHIGUS HERPETIFORMIS IN SOUTH TUNISIA: A CLINICAL EXPRESSION OF PEMPHIGUS FOLIACEUS?
Améni JERBI, H. HACHICHA, S. FEKI, E. BAHLOUL, K. SELLAMI, O. ABIDA, S. CHARFI, A. BOUZID, T. SELLAMI BOUDAWARA, H. TURKI, A. MASMOUDI, H. MASMOUDI
International Journal of Dermatology. 2018 Sep ; 57 (9) : 1094 – 1101. Doi: 10.1111/ijd.14139.

117/ UPDATE ON IMMUNOGENETICS OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.
Hatem MASMOUDI, O. ABIDA, A. MASMOUDI, H. TURKI.
Journal of Leucocyte Biology. 2019 Feb; 105(2): 257 – 265. doi: 10.1002/JLB.MR0318-132R; Review.

118/ Progression of autoantibodies anti-GAD and anti-IA2 in type 1A Diabetics aged 5 to 21 years in Côte d’ivoire.
Aïssé F.J. TREBISSOU, P. SIBAILLY, A. ANKOTCHE, M. SANOGO, D. KOUASSI, M.Th. KOUASSI, H. MASMOUDI, A.F. YAPO.
Journal of Cellular Immunology, 2019, Volume 1, Issue 1.

119/ PERFORMANCES COMPARATIVES DES TESTS IMMUNOLOGIQUES DU LIQUIDE CEPHALO-RACHIDIEN DANS LE DIAGNOSTIC DE LA
SCLEROSE EN PLAQUES.
Sabrina MEJDOUB, S. FEKI, M. DAMMAK, N. FARHAT, H. HACHICHA, Ch. MHIRI, H. MASMOUDI.
Revue Francophone des Laboratoires, n° 514, Juillet-Août 2019.

120/ CLINICAL AND SEROLOGICAL PROFILE OF SYSTEMIC SCLEROSIS IN TUNISIA: A RETROSPECTIVE OBERVATIONAL STUDY.
Raida BEN SALAH, F. FRIKHA, H. HACHICHA, I. CHABCHOUB, C. DAMMAK, M. SNOUSSI, M. JALLOULI, S. MARZOUK, H. MASMOUDI, Z. BAHLOUL.
La presse médicale, October 2019, Volume 48, Issue 10, e284-e291.
https://doi.org/10.1016/j.lpm.2019.07.037.

121/ SOUTH TUNISIAN PEMPHIGUS PATIENTS BEYOND 60 YEARS: EPIDEMIOLOGICAL PROFILE AND EVOLUTION.
Améni JERBI, H. HACHICHA, E. BAHLOUL, S. FEKI, K. SELLAMI, O. ABIDA, A. BOUZID, H. TURKI, A. MASMOUDI, H. MASMOUDI.
International Journal of Dermatology, November 2019, Volume 58, Issue11
e219-e220, doi : 10.1111/ijd.14594.

122/ NEUROMYELITIS OPTICA SPECTRUM DISORDERS IN SOUTH OF TUNISIA: A RARE ENTITY WITH LOW SEROPREVALENCE OF ANTI- AQUAPORIN 4 AUTOANTIBODIES

S. MEJDOUB, S. FEKI, M. DAMMAK, N. FARHAT , O. HDIJI, S. BOUKTHIR, H. HACHICHA, C. MHIRI, H. MASMOUDI.
Revue neurologique, 2020 May ; 176(4) : 261 – 267. Doi : 10.1016/j.neurol. 2019.
08.009. Epub 2019 Oct 24.

123/ INFECTION PAR LE NOUVEAU CORONAVIRUS : DU DEPISTAGE ET DIAGNOSTIC ANTIGENIQUES SEROLOGIQUES A L’IMMUNITE ET LA REINFECTION.
Hatem MASMOUDI.
Revue Tunisienne de Biologie Clinique, Juin 2020 ; n°2 Spécial Covid-19 ; 6-26 ; Review.

124/ CHROMOSOME 2Q33 GENETIC POLYMORPHISMS IN TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS”
Olfa ABIDA, E. BAHLOUL, M. BEN JMAA, Kh. SELLAMI, F. ZOUIDI, R. FAKHFAKH, N. MAHFOUDH, H. TURKI, H. MASMOUDI.
Molecular Genetics and Genomic Medicine, 2020; 00: e1476.
https://doi.org/10.1002/mgg3.1476.

125/ DAPSONE IN THE TREATMENT OF PEMPHIGUS FOLIACEUS: A CLINICAL SERIES OF 23 CASES AND A LITERATURE REVIEW.
Bahloul E, Hammami F, Jerbi A, Abida O, Sellami K, Hachicha H, Amouri M, Boudaya S, Mseddi M, Masmoudi H, Masmoudi A, Turki H.
Ann Dermatol Venereol. 2020 Dec ;147(12) :873-876.
Doi : 10.1016/j.annder.2020.07.007. Epub 2020 Aug 18. PMID : 32826082

126/ TOLL-LIKE-RECEPTOR GENE POLYMORPHISMS IN TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.
Abida O, Bahloul E, Elloumi N, Toumi A, Tahri S, Ben Jmaa M, Fakhfakh R, Mahfoudh N, Turki H, Masmoudi H.
Biomed Res Int. 2020 Nov 5;2020:6541761. doi: 10.1155/2020/6541761.
eCollection 2020. PMID : 33204706

127/ MELATONIN INGESTION BEFORE INTRADIALYTIC EXERCISE IMPROVES IMMUNE RESPONSES IN HEMODIALYSIS PATIENTS.
Marzougui H, Hammouda O, Ben Dhia I, Maaloul R, Agrebi I, Chaker H, Kammoun K, Ben Hmida M, Ayadi F, Kallel C, Driss T, Turki M, Masmoudi H, Hachicha H.
Int Urol Nephrol. 2021 Mar;53(3):553-562. Doi : 10.1007/s11255-020-02643-3.
Epub 2020 Sep 23.PMID: 32965623

128/ AUTOANTIBODIES AGAINST DESMOGLEIN 1 AND 3 IN SOUTH TUNISIAN PEMPHIGUS.

Jerbi A, Hachicha H, Feki S, Abida O, Bahloul E, Sellami K, Bouzid A, Turki H, Masmoudi A, Masmoudi H.
Tunis Med. 2021 Octobre;99(10):992999. PMID: 35288901

129/ RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features.
Elloumi N, Fakhfakh R, Abida O, Hachicha H, Marzouk S, Fourati M, Bahloul Z, Masmoudi H.
Int J Immunogenet. 2021 Jun;48(3):250-259. doi: 10.1111/iji.12531. Epub 2021 Mar 1. PMID: 33650302

130/ Vitamin D status and CYP27B1-1260 promoter polymorphism in Tunisian patients with systemic lupus erythematosus.
Fakhfakh R, Feki S, Elleuch A, Neifar M, Marzouk S, Elloumi N, Hachicha H, Abida O, Bahloul Z, Ayadi F, Masmoudi H.
Mol Genet Genomic Med. 2021 Mar;9(3): e1618. doi: 10.1002/mgg3.1618.
Epub 2021 Feb 17. PMID: 33594806 Free PMC article.

131/ Antinuclear antibodies in children: clinical signification and diagnosis utility.
Mejdoub S, Hachicha H, Gargouri L, Feki S, Mahfoudh A, Masmoudi H.
Tunis Med. 2021 Octobre; 99(10):980-984.PMID: 35288899

132/ ANNEXIN A1 AND ITS RECEPTOR GENE POLYMORPHISMS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE TUNISIAN POPULATION.
F. Dhaffouli, H. Hachicha, O. Abida, N. Gharbi, N. Elloumi, H. Kanoun, N. Belguith, S. Marzouk, R. Fakhfakh, S. Feki, H. Mnif, H. Kamoun, Z. Bahloul, H. Masmoudi.
Clinical Rheumatology, Jan 2022. doi.org/10.1007/s10067-022-06057-7.

133/ ASSOCIATION OF IGHM POLYMORPHISMS WITH SUSCEPTIBILITY TO TYPE 1 DIABETES.
Ferjeni Zouidi, Raouia Fakhfakh, Olfa Abida, Carlos Penha‐Goncalves, Hatem Masmoudi.
Immunol Res. 2022 Jun ; 70(3) : 325-330. Doi : 10.1007/s12026-021-09252-x. Epub 2022 Jan 20. PMID : 35048256.

134/ TH17 AND TH1 CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH FOCUS ON LUPUS NEPHRITIS.
Fakhfakh R, Zian Z, Elloumi N, Abida O, Bouallegui E, Houssaini H, Volpe E, Capone A, Hachicha H, Marzouk S, Bahloul Z, Masmoudi H.
Immunol Res. 2022 Jun 6. doi: 10.1007/s12026-022-09296-7. Online ahead of print.
PMID: 35666434.

135/ ANTINUCLEAR ANTIBODIES POSITIVITY IS NOT RARE DURING MULTIPLE SCLEROSIS AND IS ASSOCIATED WITH RELAPSING STATUS AND IGG OLIGOCLONAL BANDS POSITIVITY

Sabrina Mejdoub, Sawsan Feki, Nouha Farhat, Mariem Dammak, Hend Hachicha, Salma Sakka, Abir Ayedi, Faten Ayedi, Chokri Mhiri, Hatem Masmoudi
Revue neurologique (2022), https://doi.org/10.1016/j.neurol.2021.11.016.

136/ AUTOANTIBODIES TO ZINC TRANSPORTER 8 AND SLC30A8 GENOTYPE IN TYPE 1 DIABETES CHILDHOOD : A PIONEERING STUDY IN NORTH AFRICA.
Fakhfakh R, Kmiha S, Tahri S, Feki S, Zouidi F, Abida O, Hachicha M, Kammoun T, Masmoudi H.
J Diabetes Res. 2022 May 23;2022: 2539871. doi: 10.1155/2022/2539871. eCollection 2022.PMID: 3565636.

137/ ROLE OF INNATE IMMUNE RECEPTORS TLR 4 AND 2 POLYMORPHISMS IN SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY
N. Elloumi, S. Tahri, R. Fakhfakh, O. Abida, N. Mahfoudh, H. Hachicha, S. Marzouk, Z. bahloul, H. Masmoudi
Ann Hum Genet. 2022 May; 86(3):137-144. Doi : 10.1111/ahg.12458. Epub 2022
Feb 7. PMID : 35128637.

138/ PEMPHIGUS HERPETIFORMIS IN A 4-YEAR-OLD CHILD: CASE REPORT AND REVIEW OF THE LITERATURE
F. Hayder, E. Bahloul, K. Sellami, A. Jerbi, H. Masmoudi, M. Zghal, L. Ayedi, A. Aounallah, H. Turki.
Clin Case Rep. 2022; 10:e05567. doi:10.1002/ccr3.5567.

139/ EVALUATION OF X CHROMOSOME INACTIVATION IN ENDEMIC TUNISIAN PEMPHIGUS FOLIACEUS.
ABIDA O, Elloumi N, Bahloul E, Hachicha H, Sellami Kh, Fakhfakh R, Marzouk S, Ben Ayed I, Mahfoudh N, Turki H, Masmoudi H.
Molecular Genetics and Genomic Medicine. 09 November 2022.
doi.org/10.1002/mgg3.2080. doi: 10.1002/mgg3.2080. Epub 2022 Nov 9.
PMID: 36349750.

140/ ROLE OF INNATE IMMUNE RECEPTORS TLR 4 AND 2 POLYMORPHISMS IN SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY
Elloumi N, Safa Tahri, Raouia Fakhfakh, Olfa Abida, Nadia Mahfoudh, Hend Hachicha, Sameh Marzouk, Zouhir Bahloul, Hatem Masmoudi
Ann Hum Genet. 2022 May;86(3):137-144. doi: 10.1111/ahg.12458. Epub 2022 Feb
7. PMID: 35128637

141/ TH17 AND TH1 CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH FOCUS ON LUPUS NEPHRITIS.
Fakhfakh R, Zian Z, Elloumi N, Abida O, Bouallegui E, Houssaini H, Volpe E,
Capone A, Hachicha H, Marzouk S, Bahloul Z, Masmoudi H.
Immunol Res. 2022 Jun 6. doi: 10.1007/s12026-022-09296-7. Online ahead of print.
PMID: 35666434

142/ ANTI-MITOCHONDRIAL ANTIBODIES DETECTION ASSAYS FOR DIAGNOSIS OF PRIMARY BILIARY CHOLANGITIS IN SOUTHERN
TUNISIA POPULATION
S. Mejdoub, Z. Hamza, H. Hachicha, L. Chtourou, S. Marrzouk, S. Feki, A. Jerbi, S. Boukthir, Z. Bahloul, N. Tahri, H. Masmoudi.
Ann Biol Clin (Paris). 2022 Sep 1 ; 80(5) :423-429. doi:10.1684/abc.2022.1761.PMID: 36453746

143/ INTRATHECAL B CELL-RELATED MARKERS FOR AN OPTIMIZED BIOLOGICAL INVESTIGATION OF MULTIPLE SCLEROSIS PATIENTS
Sawsan Feki, Mariem Damak, Salma Sakka, Yesmine Ben Ali, Sabrina Mejdoub, Nadia Bouattour, Hend Hachicha, Chokri Mhiri, Hatem Masmoudi.
www.nature.com/scientificreports Scientific Reports | (2022) 12 :16425 | https://doi.org/10.1038/s41598-022-19811-3 144/ DIFFERENTIAL EXPRESSION OF ANTI-INFLAMMATORY RNA BINDING PROTEINS IN LUPUS NEPHRITIS.
Fakhfakh R, Bouallegui E, Houssaini H, Elloumi N, Dhafouli F, Abida O, Hachicha H, Marzouk S, Bahloul Z, Kammoun K, Boudawara T, Masmoudi H. Life (Basel).
2022 Sep 23 ;12(10) :1474. Doi :10.3390/life12101474.
PMID : 36294909

145/ EPIDEMIOLOGICAL STUDY ON THE EVALUATION OF MOLECULAR AND IMMUNOLOGICAL ASSAY FOR THE DETECTION OF TOXOPLASMA GONDII IN WOMEN’S ABORTION.
Alkardhi IKA, Masmoudi H, Muhammedand HA, Sellami H.
Cell Mol Biol (Noisy-le-grand). 2022 Apr 30 ; 68(4) :122-128.
Doi : 10.14715/cmb/2022.68.4.15.PMID : 35988283

146/ BICLONAL GAMMOPATHIES IN SOUTH TUNISIA: CLINICAL AND
BIOLOGICAL CHARACTERISTICS.
Jerbi A, Hachicha H, Charfi A, Kallel F, Feki S, Ben Ayed M, Ayadi F, Akrout R,
Frikha F, Amouri A, Kammoun K, Mdhaffar M, Ben Hmida M, Tahri N, Bahloul Z,
Baklouti S, Elloumi M, Masmoudi H.
Lab Med. 2023 Sep 5;54(5):464-468. doi: 10.1093/labmed/lmac153.
PMID: 36799924

147/ COWS’ MILK ALTERNATIVES FOR CHILDREN WITH COWS’ MILK
PROTEIN ALLERGY – REVIEW OF HEALTH BENEFITS AND RISKS OF
ALLERGIC REACTION
Roua Lajnaf, Sawsan Feki, Salma Ben Ameur, Hamadi Attia, Thouraya Kammoun,
Mohamed Ali Ayadi, Hatem Masmoudi
International Dairy Journal, 24 February 2023, 105624;
https://doi.org/10.1016/j.idairyj.2023.105624
148/ THE PRESENCE OF TWO LIGHT CHAIN BANDS ON
IMMUNOFIXATION IS ASSOCIATED WITH POOR OUTCOMES IN NEWLY
DIAGNOSED MULTIPLE MYELOMA PATIENTS.
Jerbi A, Turki O, Hachicha H, Kallel Sarbeji F, Feki S, Mejdoub S, Kammoun K,
Ben Hmida M, Elloumi M, Masmoudi H.
Ann Hematol. 2023 Jun;102(6):1459-1466. doi: 10.1007/s00277-023-05221-6.
Epub 2023 Apr 15. PMID: 37060464
149/ CHARACTERISTICS OF ADULT-ONSET AUTO-IMMUNE TYPE 1
DIABETES.
Kacem FH, Jerbi A, Allymamod BT, Abed WB, Mnif M, Charfi N, Elleuch M,
Rekik N, Masmoudi H, Abid M.
Am J Med Sci. 2023Jul; 366(1):49-56. doi: 10.1016/j.amjms.2023.04.009. Epub
2023 Apr 22.PMID: 37088301
150/ miRNA IMPLICATION IN THE PATHOGENESIS AND THE OUTCOME
OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.
Khabou B, Fakhfakh R, Tahri S, Bahloul E, Hadj Kacem H, Belmabrouk S,
Hachicha H, Sellami K, Turki H, Masmoudi H, Abida O.
Exp Dermatol. 2023 Jul;32(7):1132-1142. doi: 10.1111/exd.14821. Epub 2023 Apr
28.PMID: 37114366
151/ GENES REGULATING OXIDATIVE-INFLAMMATORY RESPONSE IN
CIRCULATING MONOCYTES AND NEUTROPHILS IN SEPTIC SYNDROME
Elloumi N, Bahloul M, Benabdallah E, Kharrat S, Fakhfakh R, Bouchaala K, Abida
O, Chtara K, Masmoudi H, Bouaziz M.
Biol Futur. 2023 Jun;74(1-2):199-207. doi: 10.1007/s42977-023-00168-1. Epub
2023 Jun 8.PMID: 37291472

152/ HUMAN EPIDERMAL KERATINOCYTES AND HUMAN DERMAL
FIBROBLASTS INTERACTIONS SEEDED ON GELATIN HYDROGEL FOR
FUTURE APPLICATION IN SKIN IN VITRO 3-DIMENSIONAL MODEL
Tahri Safa, Maarof M, Masri S, Che Man R, Masmoudi H, Fauzi MB.
Front Bioeng Biotechnol. 2023 Jun 23;11:1200618. doi: 10.3389/fbioe. 2023.
1200618. eCollection 2023.PMID: 37425369
153/ ICOS GENE POLYMORPHISMS IN SYSTEMIC LUPUS
ERYTHEMATOSUS: A CASE-CONTROL STUDY
Hana Houssaini, Emna Bouallegui, Olfa Abida, Safa Tahri, Nesrine Elloumi, Hend
Hachicha, Sameh Marzouk, Zouhir Bahloul, Masmoudi Hatem, Raouia Fakhfakh
Int J Immunogenet. 2023 Aug;50(4):194-205. doi: 10.1111/iji.12625. Epub 2023
Jun 20.PMID: 37338463
154/ RECENT ADVANCES IN SELECTIVE ALLERGIES TO MAMMALIAN
MILK PROTEINS NOT ASSOCIATED WITH COW’S MILK PROTEINS
ALLERGY.
Lajnaf R, Feki S, Ben Ameur S, Attia H, Kammoun T, Ayadi MA, Masmoudi H.
Food Chem Toxicol. 2023 Aug;178:113929. doi: 10.1016/j.fct.2023.113929. Epub
2023 Jul 3.PMID: 37406758 Review.
155/ VITAMIN D DEFICIENCY IN RELATION WITH THE SYSTEMIC AND
CENTRAL INFLAMMATION DURING MULTIPLE SCLEROSIS.
Feki S, Naifar M, Dammak M, Majdoub S, Sakka S, Ben AY, Hachicha H, Mhiri
C, Ayadi F, Masmoudi H.
J Med Biochem. 2023 Aug 25;42(3):364-375. doi: 10.5937/jomb0-37676.
PMID: 37814621
156/ TUBULAR EXPRESSION OF TOLL-LIKE RECEPTOR 9 IN LUPUS AND
PRIMARY MEMBRANOUS NEPHROPATHY.
Elloumi N, Fakhfakh R, Masmoudi H, Kammoun K.
Tunis Med. 2024 Apr 5 ;102(4) :241-244. doi :
10.62438/tunismed.v102i4.4273.PMID: 38746965
157/ DIRECT MEDICAL COST RELATED TO THE MANAGEMENT OF
PEMPHIGUS: A PILOT TUNISIAN STUDY.
Hayder F, Bahloul E, Yaich S, Turki S, Sellami K, Litaiem N, Masmoudi H, Turki
M, Turki H.
Tunis Med. 2024 Feb 5;102(2):74-77. doi:
10.62438/tunismed.v102i2.4651.PMID: 38567471
158/ UNRAVELING THE ROLE OF THE VITAMIN D-VDR PATHWAY IN
PEMPHIGUS VULGARIS FROM TUNISIAN PATIENTS.

DHAFFOULI F, ELLOUMI N, TAHRI S, SELLAMI K, MSEDDI M, FRIKHA
R, BAHLOUL E, CHARFI A, TURKI H, HACHICHA H, MASMOUDI H,
ABIDA O.STEROIDS. 2024 SEP;209:109454. DOI:
10.1016/J.STEROIDS.2024.109454. EPUB 2024 JUN 13.PMID: 38878876
159/ EXPLORING THE ROLE OF VITAMIN D-VDR PATHWAY IN
PEMPHIGUS FOLIACEOUS: A NOVEL PERSPECTIVE ON DISEASE
PATHOGENESIS.
TAHRI S, ELLOUMI N, KHABOU B, FRIKHA R, TURKI H, MAHFOUDH N,
BAHLOUL E, HACHICHA H, MASMOUDI H, ABIDA O.
ARCH DERMATOL RES. 2024 JUL 3;316(7):449. DOI: 10.1007/S00403-024-
03192-W.PMID: 38958777
160/ Infrequent patterns in cerebrospinal fluid isofocusing test: Clinical significance
and contribution of IgG index and Reiber diagram to their interpretation.
Maaloul M, Mejdoub S, Sakka S, Hachicha H, Dammak M, Koubaa F, Mhiri
C, Masmoudi H, Feki S.
Mult Scler Relat Disord. 2024 Apr;84:105509. doi: 10.1016/j.msard.2024.105509.
Epub 2024 Feb 18.PMID: 38422634